We are live on
!
Find out more
OCM
Opti Capital Management Portfolio holdings
AUM
$1.64B
1-Year Est. Return
0%
This Fund
S&P 500
This Quarter
Est. Return
-0%
1 Year Est. Return
0%
3 Year Est. Return
-0.01%
5 Year Est. Return
+0.33%
10 Year Est. Return
–
AUM
$2.23B
AUM Growth
+$528M
(+31%)
Cap. Flow
-$1.46B
Cap. Flow
% of AUM
-65.47%
Top 10 Holdings %
Top 10 Hldgs %
44.57%
Holding
66
New
2
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gossamer Bio
GOSS
|
+$156K |
| 2 |
Karyopharm Therapeutics
KPTI
|
+$101K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 99.99% |
| 2 | Healthcare | 0.01% |
Similar funds
MRG
MB
EPW
TWM
MA
HCMG
LFS
TIM
Opti Capital Management's Q4 2024 Portfolio in Review
As of Q4 2024, Opti Capital Management held 66 positions worth $2.23B, up 31% from $1.71B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Opti Capital Management withdrew a net $1.46B in Q4 2024.
By sector, the portfolio is most concentrated in Miscellaneous at 100% of assets, followed by Healthcare.
Against the trend, Opti Capital Management opened a new position in Gossamer Bio worth $165K.
- Opti Capital Management's largest Q4 2024 buy was Gossamer Bio: 182,319 shares worth $165K.
- Opti Capital Management's ten largest holdings make up 45% of its $2.23B portfolio in Q4 2024.
- Opti Capital Management opened 2 new positions and closed 0 in Q4 2024.
- Opti Capital Management's portfolio value rose 31% quarter-over-quarter to $2.23B.
Based on Opti Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.